BioCentury
ARTICLE | Finance

VarmX attracts investor syndicate with financial reserves to support coagulation company beyond €32M series B

July 8, 2020 8:44 PM UTC

Investors in VarmX’s €32 million ($36.1 million) series B round brought together a deep-pocketed syndicate designed to support the Netherlands-based coagulation play through registrational studies for its lead program.

INKEF Capital and Ysios Capital co-led the round, joined by fellow new investors LSP and Lundbeckfonden Ventures and existing investors BioGeneration Ventures and InnovationQuarter...